Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Kaken describes novel antibacterial agents

Jan. 7, 1997

Yale receives grant from Vion

Jan. 3, 1997

Novel cephalosporins reported by Japanese investigators

Jan. 3, 1997

Once-daily oral antibiotic from RPR cleared by FDA

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

New cephalosporins from LG Chemical

Dec. 30, 1996

Lilly describes potential antirhinoviral compounds

Dec. 24, 1996

Forest cleared to market new treatment for cystitis

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...